Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 4,287

• Price / Volume Information    Yesterday's Closing Price: $18.67 Daily Weekly Monthly 20 Day Moving Average: 146 shares Shares Outstanding: 469.71 (millions) Market Capitalization: $8,769.45 (millions) Beta: 0.25 52 Week High: $18.67 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 33.36% 35.38% 12 Week 43.28% 38.40% Year To Date 45.07% 45.27%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers Akira Sagara - Chief Executive Officer; Chairman and Director Takino Toichi - Chief Operating Officer; President and Director Akihiro Tsujinaka - Executive Vice President and Director Masao Nomura - Director Akiko Okuno - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASI) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 469.71 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.25 Market Capitalization: $8,769.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 20.98 PEG Ratio: - Price Ratios Price/Book: 1.60 Price/Cash Flow: 17.33 Price / Sales: 2.57 EPS Growth vs. Year Ago Period: 90.48% vs. Previous Quarter: 25.00% Sales Growth vs. Year Ago Period: 3.07% vs. Previous Quarter: 3.33% ROE 12/31/25 - 7.76 09/30/25 - 6.13 06/30/25 - 5.47 ROA 12/31/25 - 5.91 09/30/25 - 4.64 06/30/25 - 4.12 Current Ratio 12/31/25 - 3.02 09/30/25 - 2.99 06/30/25 - 2.99 Quick Ratio 12/31/25 - 2.56 09/30/25 - 2.50 06/30/25 - 2.44 Operating Margin 12/31/25 - 12.29 09/30/25 - 9.75 06/30/25 - 8.75 Net Margin 12/31/25 - 12.29 09/30/25 - 9.75 06/30/25 - 8.75 Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - 11.70 09/30/25 - 11.76 06/30/25 - 11.43 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 0.10 09/30/25 - 0.11 06/30/25 - 0.13 Debt-to-Capital 12/31/25 - 8.89 09/30/25 - 9.98 06/30/25 - 11.13

Powered by Zacks Investment Research ©